Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant chemotherapy in upper tract urothelial cancer
NCT01993979Phase 3Unknown
- Sponsor
- The Institute of Cancer Research
- Start
- May 2012
- Primary completion
- Nov 2018
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine, cisplatin, carboplatin in upper tract urothelial carcinoma (UTUC), sponsored by The Institute of Cancer Research. Status: unknown.
02
Drugs
gemcitabinecisplatincarboplatin
03
Conditions
upper tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on NCT01993979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01993979.